ENTITY
China Biologic Products

China Biologic Products (CBPO US)

27
Analysis
Health CareUnited States
China Biologic Products Holdings, Inc. operates as a biopharmaceutical company. The Company researches, develops, and produces human plasma-based pharmaceutical and coagulation factor products in the form of tablets, injections, capsules, and syrups. China Biologic Products also distributes pharmaceutical products. China Biologic Products serves clients in China.
more
Refresh
13 Feb 2024 18:04

IKang Healthcare (KANG US): Another Setback For Dissenters

In officially decided cases concerning dissentient shareholders in privatised US-listed China plays, the uplift to the takeover price versus time...

Logo
328 Views
Share
bullishChindata Group
05 Dec 2023 15:38

Dissenters Mobilise As Chindata (CD US)'s Shareholders Approve Bain's Offer

This is done. Trading at a 2% gross spread to terms, or ~14% annualised assuming late-Jan completion. Not bad. Not great. It was certainly more...

Logo
465 Views
Share
27 Sep 2021 17:00

IClick(ICLK US): PAG & Oasis Shake The Trees

Buying around here is probably going to have limited downside. I think PAG/Oasis' intent is to shake out potential suitors - including the co...

Logo
347 Views
Share
06 Aug 2021 13:06

New Frontier (NYSE: NFH): Healthcare Homecoming

I see the gross/annualised spread at 7.4%/19.8%, assuming late December completion.  This looks like a pretty clean deal for around five months of...

Logo
405 Views
Share
18 Jul 2021 09:05

China Healthcare Weekly (July.16)

The article mainly analyzed China's plan to accelerate the construction of plasma stations, promising outlook of medical IT industry...

Logo
230 Views
Share
x